Legal Library: Search

1111011 Informal Interpretation

Date

November 29, 2011

Rule

802.3, 801.10

Refer to BOLD Italics for comments.

Original Image File (95.01 KB)

1111011 Informal Interpretation

Date

November 29, 2011

Rule

802.3, 801.10

Refer to BOLD Italics for comments.

Original Image File (95.01 KB)

Express Consolidation, Inc., et al.

Type of Action

Federal

Last Updated

November 29, 2011

FTC Matter/File Number

052-3146

Federal Register Notice

Agency Information Collection Activities; Request for OMB Review; Comment Request: Notice and Request for Comment (Alcohol Reports)

Date

November 29, 2011

1111010 Informal Interpretation

Date

November 28, 2011

Rule

801.10

Agree.

Original Image File (90.89 KB)

1111010 Informal Interpretation

Date

November 28, 2011

Rule

801.10

Agree.

Original Image File (90.89 KB)

BuyExclusive.Net (Gene Kim), U.S.

Type of Action

Federal

Last Updated

November 28, 2011

FTC Matter/File Number

112 3043

Royal Tronics, Inc. d/b/a MyCandyEyes.com, and Jamil Hindi, U.S.

Type of Action

Federal

Last Updated

November 28, 2011

FTC Matter/File Number

112 3044

MyCuteLens.com (Thy Xuan Ho a/k/a Brandon Lee), U.S.

Type of Action

Federal

Last Updated

November 28, 2011

FTC Matter/File Number

112 3042

Federal Register Notice

The Appliance Labeling Rule: Advance Notice of Proposed Rulemaking and Request For Public Comment - Required Disclosures for Determining Whether a Furnace, Central Air Conditioner, or Heat Pump Meets New Department of Energy Standards, 16 C.F.R. Part 305

Date

November 28, 2011

Federal Register Notice

Pool Corporation; Analysis to Aid Public Comment; Proposed Consent Agreement

Date

November 28, 2011

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs

Date

November 28, 2011

Mary K. Engle, Associate Director

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs (275.23 KB)

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs

Date

November 28, 2011

Mary K. Engle, Associate Director

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs (51.69 KB)

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs

Date

November 28, 2011

Mary K. Engle, Associate Director

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs (46.78 KB)

Commissioner Statements

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs

Date

November 28, 2011

Mary K. Engle, Associate Director

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs (153.32 KB)

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs

Date

November 28, 2011

Mary K. Engle, Associate Director

Joint FDA/FTC Warning Letter Concerning Product Labeling of Human Chrorionic Gonadotropin (HCG) Drugs (44.77 KB)